Ocular Therapeutix, Inc. (OCUL)
NGM – Real Time Price. Currency in USD
10.27
+0.51 (5.23%)
Market open: Aug 12, 2026, 11:20 AM EDT
9.80
+0.04 (0.41%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
10.27
+0.51 (5.23%)
Market open: Aug 12, 2026, 11:20 AM EDT
9.80
+0.04 (0.41%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $598.6M significantly exceed its total debt $79.4M, ensuring strong financial flexibility
Total current assets $644.4M exceed Total current liabilities $49.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-29.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$70.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.11 | 6.05 | 10 | |
| Quick ratio | 13.03 | 5.63 | 10 | |
| Debt to Equity | 0.15 | 0.30 | 9.0 | |
| Debt to Assets | 0.12 | 1.04 | 8.0 | |
| Interest coverage | -29.41 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 51M | 58M | 64M | 52M | 52M |
| Gross Profit | 47M | 53M | 58M | 45M | 45M |
| Operating Income | -79M | -82M | -172M | -270M | -314M |
| Net Income | -71M | -81M | -194M | -266M | -301M |
| EBITDA | -77M | -79M | -168M | -266M | -308M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -1.81 | 4.17 | 2.5 |
| Next quarter | 7.36 | -32.18 | 3.0 |
| Current year | 1.77 | -5.34 | 2.0 |
| Next year | 90.37 | 0.45 | 6.0 |
| Weighted average score | 3.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 24.94 | 11.11 | 12.5 | 0.02 | 6.5 |
| Y/Y | 0.12 | -16.14 | 10.26 | -25.05 | 2.8 |
| 3y average | 1.35 | -63.57 | -15.63 | -52.72 | 1.5 |
| 5y average | 34.49 | -215.79 | -174.52 | -35.14 | 3.3 |
| Weighted average score | 3.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |